Medical News, Journals & Upcoming Events
Most Read Psychiatry Articles on JAMA Network
- Cognitive Behavior Therapy for Mental Disorders in Adults April 16, 2025This unified series of meta-analyses examines the effect sizes of cognitive behavior therapy for many mental and eating disorders on symptoms of the respective disorders using uniform methodologies for data extraction, risk of bias assessment, and meta-analytic techniques.
- Lessons Learned From Drug Decriminalization Remedies in British Columbia April 14, 2025In light of a continuing public health emergency resulting from dramatic increases in drug-related deaths during the past 25 years, the seemingly impenetrable wall of universal prohibition laws criminalizing, among other things, possession and use of psychoactive drugs (other than alcohol and cannabis) has begun to fracture as the more traditional drug policy stance has […]
- Clinician Suicide Risk Assessment for Prediction of Suicide Attempt in a Large Health Care System April 9, 2025This electronic health record–based, prognostic study compares routine clinical suicide risk assessment for prospectively predicting suicide attempt using stratified prevalence vs machine learning models in patients aged 5 years or older treated by clinicians in outpatient, inpatient, and emergency department encounters.
- Convergence of Cannabis and Psychosis on the Dopamine System April 9, 2025This cohort study investigates the association between cannabis and the midbrain dopamine pathway involved in psychosis.
- Esketamine Combined With SSRI or SNRI for Treatment-Resistant Depression April 2, 2025This comparative effectiveness study uses data from the TriNetX network to determine whether the combination of esketamine and a serotonin-norepinephrine reuptake inhibitor (SNRI) shows differences in clinical outcomes compared to esketamine and a selective serotonin reuptake inhibitor (SSRI) in patients with treatment-resistant depression.
JAMA Oncology Current Issue
- Novel Combination Immunotherapy and Clinical Activity in Patients With HPV-Associated Cancers April 1, 2025This nonrandomized clinical trial examines the clinical activity and adverse events of a novel combination treatment for advanced human papillomavirus–associated cancers.
- Can Knowledge From Treating Chronic Myeloid Leukemia Inform Therapy of EGFR -Mutant Lung Adenocarcinoma? April 1, 2025This Viewpoint discusses how therapy of chronic myeloid leukemia can inform therapy of lung cancer.
- Improving the Clinical Utility of FRAX in Patients With Cancer—The Need for More Detailed Analysis April 1, 2025To the Editor We commend Ye et al for their comprehensive analysis of fracture risk using the Fracture Risk Assessment Tool (FRAX) in individuals with cancer. This study provides valuable insights into fracture risk among patients with cancer, an area that warrants attention due to the unique health challenges faced by this population. However, several […]
- Improving the Clinical Utility of FRAX in Patients With Cancer—The Need for More Detailed Analysis—Reply April 1, 2025In Reply We thank Zhang and Xu and Lien et al for their thoughtful comments on our recent article examining fracture risk prediction in individuals with cancer. Cancer therapies and outcomes have indeed evolved over the observation period of our study. Although stratifying our analysis for different time periods would be interesting, performing validation studies […]
Upcoming Events
To receive information about upcoming events and the latest CE Activities, join our network.
Recent Activities
RMEI CE Featured Activities
REGISTER TO ATTEND